The Cancer Research Institute is deeply grateful for the leadership and guidance of its volunteer Board of Trustees, which includes highly accomplished leaders in diverse professions. Trustees make significant, long-term commitments in support of CRI's mission through strategic governance, active participation in CRI initiatives, and financial support.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Dr. Kunle Odunsi, of the University of Chicago Medicine Comprehensive Cancer Center, answers questions about immunotherapy clinical trials after the 2021 CRI Virtual Immunotherapy Patient Summit.
Dr. Ellen Puré, of the University of Pennsylvania, answers questions about the basics of immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit.